Stay updated with breaking news from Scientific Strategy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript April 30, 2024 Exelixis, Inc. misses on earnings expectations. Reported EPS is $0.17 EPS, expectations were $0.28. EXEL isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, ladies and gentlemen, and […]
Exelixis, Inc. misses on earnings expectations. Reported EPS is $0.17 EPS, expectations were $0.28.
Advance your career as an effective, inclusive leader in STEM through this four-part series brought to you by the New York Academy of Sciences with special guest speakers from Pfizer senior leadership.
Call for the recruitment of excellent researchers 2024 job in Lleida (Provincia), Cataluña (ES) with Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré. Apply Today.
Grant awarded in 2021 to honor Rhonda Crocker Howell and her contributions to the metastatic breast cancer community